Management of Dysuria After Prostate Cancer Treatment

Initial Assessment

• Determine whether dysuria is irritative (radiation‑induced mucositis/edema) or obstructive (urethral stricture or bladder neck contracture), as this distinction drives subsequent management. [1][2]
• Record timing of symptom onset (acute vs. late after therapy) to differentiate treatment‑related inflammation from delayed structural complications. 1
• Characterize dysuria: burning/painful urination suggests irritative pathology, whereas hesitancy, weak stream, or incomplete emptying points to obstruction. [1][2]
• Document associated urinary symptoms (frequency, urgency, nocturia, hematuria, retention) to guide work‑up. 1
• Note the type of prostate cancer treatment received (surgery, external‑beam radiation, brachytherapy, or combined modality) because risk profiles differ. [3][1]
• Physical exam finding of suprapubic fullness is indicative of urinary retention and warrants post‑void residual measurement. 1

Diagnostic Work‑Up

Irritative Symptom Pathway

• Up to 50 % of men experience irritative urinary symptoms (frequency, urgency, dysuria) during the acute phase of radiation therapy. 3
• Initiate a trial of anticholinergic medication (e.g., oxybutynin) for presumed overactive bladder; overactive bladder occurs in ≈48 % of post‑treatment patients. [4][5]1
• Perform urinalysis and urine culture to exclude urinary‑tract infection as a reversible cause. 1
• If symptoms persist despite anticholinergics, consider urodynamic testing to assess bladder storage function. [1][2]
• Follow the American Urological Association (AUA) Overactive Bladder guideline for refractory cases. [4][5]

Obstructive Symptom Pathway

• Obstructive complaints (weak stream, hesitancy, incomplete emptying) raise suspicion for urethral stricture or bladder neck contracture after radiation. [1][2]
• Measure post‑void residual volume to quantify retention and monitor response to therapy. [1][2]
• Begin a trial of an α‑blocker (e.g., tamsulosin) to reduce outlet resistance. [1][2]
• Cystourethroscopy is mandatory before any surgical intervention to directly visualize the urethra, bladder neck, or possible fistula. 4
• Urethral stricture develops in ≈2 % of post‑radiation patients, with higher incidence after prior transurethral resection of the prostate (TURP). 3

Conservative (First‑Line) Management

Irritative Symptoms

• Anticholinergic therapy (e.g., oxybutynin) as initial pharmacologic step. [1][2]
• Implement behavioral modifications (bladder training, fluid management) per AUA Overactive Bladder recommendations. [4][5]

Obstructive Symptoms

• α‑blocker trial (tamsulosin) to improve urinary flow. [1][2]
• Ongoing monitoring of post‑void residuals to detect worsening retention. 1

Escalation and Referral

• If obstructive symptoms persist despite α‑blocker therapy, refer to urology for cystourethroscopy and definitive stricture management (dilation, internal urethrotomy, or urethroplasty). [4][1]
• For irritative symptoms refractory to anticholinergics, also refer per AUA guidelines for advanced evaluation and possible intravesical therapy. [4][5]

Late Radiation‑Related Complications

• Radiation‑induced urinary complications can manifest months to years after treatment completion, including urethral stricture and bladder neck contracture. [3][1]

Indications for Immediate Urology Referral

• Urinary retention requiring catheterization. 1
• Gross hematuria accompanied by dysuria. 1
• Failure of conservative management after 4–6 weeks of appropriate therapy. [1][2]

Routine Urology Referral

• Persistent obstructive symptoms despite α‑blocker therapy. [1][2]
• Irritative symptoms that remain bothersome despite anticholinergic treatment. [1][2]